Date | Exposure | Duration | Target lesions in lung (LD×SD, millimeter) | Target lesions in brain (LD×SD, millimeter) |
---|---|---|---|---|
2015.04 | Baseline | N/A | 35 × 24 | 6.5 × 4.2 |
2015.06 | AP | 2 cycles | 48 × 42 | 5.1 × 4.0 |
2015.07 | Icotinib | 1 month | 22 × 17 | 2.3 × 2.1 |
2015.09 | Icotinib | 3 months | 21 × 18 | 2.0 × 1.8 |
2015.12 | Icotinib | 6 months | 23 × 21 | 0 |
2016.02 | Icotinib | 8 months | 29 × 26 | 0 |
2016.04 | AZD9291 | 1 month | 17 × 15 | N/A |
2016.06 | AZD9291 | 3 months | 18 × 17 | N/A |
2016.09 | AZD9291 | 6 months | 20 × 16 | N/A |
2017.01 | AZD9291 | 10 months | 61 × 48 | 0 |
2017.03 | Docetaxel | 2 cycles | 88 × 39 | Multiple lesions |
2017.05 | Icotinib | 2 months | 90 × 49 | 0 |
2017.06 | Icotinib | 3 months | 64 × 28 | N/A |
2017.09 | Icotinib | 6 months | 71 × 38 | 7.1 × 4.2, 3.4 × 2.2 |
2017.11 | Icotinib | 8 months | 78 × 53 | 9.5 × 7.1, 6.0 × 5.3 |
2017.12 | WBRT | 15F | N/A | N/A |
2018.02 | AZD9291 | 1 month | 58 × 43 | 3.0 × 2.1, 0 |